SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-07-000224
Filing Date
2007-07-31
Accepted
2007-07-31 13:42:24
Documents
2
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1102
2 vltsdelistreason.txt EX-99.25 1573
  Complete submission text file 0001354457-07-000224.txt   4847
Mailing Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010
Business Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010 (650) 697-1900
Urigen Pharmaceuticals, Inc. (Subject) CIK: 0000932352 (see all company filings)

IRS No.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 25-NSE | Act: 34 | File No.: 000-22987
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850
Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144
NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE